ArticleFrontiers in oncology2024

MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma.

Jinmin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.